|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 104.43 USD | -0.75% |
|
103.90 | -0.51% |
| 07-29 | Deutsche Bank Adjusts CVS Health Price Target to $116 From $92 | MT |
| 07-29 | X, World Federation of Advertisers settle litigation over GARM dispute | RE |
| Market Cap | 133B 116B 108B 98.99B 187B 12,720B 190B 1,271B 499B 6,332B 500B 489B 21,234B | P/E 2026 * |
16.7x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 189B 164B 153B 140B 265B 18,043B 269B 1,803B 708B 8,983B 710B 694B 30,120B | EV / Sales 2026 * |
0.46x | EV / Sales 2027 * | 0.43x |
| Free-Float |
71.2% | Yield 2026 * |
2.54% | Yield 2027 * | 2.62% |
Last Transcript: CVS Health Corporation
| 1 day | -0.75% | ||
| 1 week | -3.07% | ||
| 1 month | +0.95% | ||
| 3 months | +25.38% | ||
| 6 months | +40.14% | ||
| Current year | +31.59% |
| 1 week | 103.01 |  | 110 |
| 1 month | 101.78 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 61.35 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.75% | -3.07% | +68.16% | +39.82% | 133B | |
| +1.72% | +5.34% | +13.73% | +47.57% | 87.16B | |
| -0.80% | +1.64% | +6.05% | +56.05% | 28.85B | |
| -0.55% | +2.26% | +39.19% | +72.33% | 25.72B | |
| -0.63% | +9.25% | -10.37% | -18.69% | 21.9B | |
| +0.81% | +9.25% | +57.97% | +240.93% | 20.51B | |
| +0.51% | +1.98% | +71.04% | +135.41% | 15.41B | |
| +0.64% | +3.77% | +6.58% | -3.78% | 14.98B | |
| +0.36% | +2.73% | -0.07% | -5.87% | 13.55B | |
| -2.48% | +1.58% | -11.68% | +85.10% | 11.2B | |
| Average | -0.12% | +3.47% | +24.06% | +64.89% | 37.25B | |
| Weighted average by Cap. | +0.03% | +1.87% | +36.20% | +54.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 356B 331B 304B 574B 39,084B 583B 3,905B 1,533B 19,458B 1,538B 1,504B 65,245B | 427B 371B 345B 317B 599B 40,735B 608B 4,070B 1,597B 20,279B 1,603B 1,567B 68,000B |
| Net income | 8.04B 6.99B 6.51B 5.98B 11.29B 768B 11.46B 76.73B 30.11B 382B 30.21B 29.55B 1,282B | 9.35B 8.12B 7.56B 6.94B 13.11B 892B 13.31B 89.14B 34.98B 444B 35.1B 34.33B 1,489B |
| Net Debt | 55.76B 48.48B 45.12B 41.43B 78.23B 5,323B 79.44B 532B 209B 2,650B 209B 205B 8,886B | 52.15B 45.33B 42.2B 38.74B 73.16B 4,978B 74.29B 497B 195B 2,478B 196B 192B 8,310B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$104.43 | -0.75% | 7,081,286 |
| 26-07-30 | US$105.22 | -0.66% | 7,738,249 |
| 26-07-29 | US$105.92 | -3.13% | 7,718,243 |
| 26-07-28 | US$109.34 | +2.12% | 6,682,269 |
| 26-07-27 | US$107.07 | -0.62% | 7,857,618 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
